European Academy of Dermatology and Venerology
Ended7 months ago More20 Oct 2011
VITILIGO PREVALENCE IN THE WORLD:
>3% *from 1 to 8% depending on region prevalencePhotodermatology, Photoimmunology & Photomedicine Volume 28, Issue 2, pages 84–90, April 2012 Summary Background/Purpose Narrow-band ultraviolet B (NB-UVB) is considered...
British Journal of Dermatology Volume 166, Issue 3, pages 658–661, March 2012 Summary Background Vitiligo is a common acquired depigmentation disorder caused by the loss...
Author Information 1Department of Dermatology and Pediatric Dermatology, National Centre for Rare Skin Disorders, Hôpital Pellegrin-Enfants, CHU de Bordeaux, Bordeaux,...
Autoimmunity Reviews Volume 10, Issue 12, October 2011, Pages 762-765 Manuel Sandoval-Cruza, b, Mario García-Carrascoc, d, Corresponding Author Contact Information, E-mail...
J Am Acad Dermatol. 2011 Sep;65(3):473-91. Source Department of Medical Education, MacNeal Hospital, Berwyn, Illinois. Abstract Vitiligo is an acquired pigmentary disorder of...
Allergol Int. 2011 Jul 25. http://www.ncbi.nlm.nih.gov/pubmed/21778811 Source Department of Dermatology, Kinki University Faculty of Medicine, Osaka, Japan. Abstract Background:...
Am J Clin Dermatol. 2011 Aug 1;12(4):277-81. doi: 10.2165/11318020-000000000-00000. Source Department of Dermatology, Huashan Hospital, Fudan University, Shanghai,...
J Invest Dermatol. 2011 Aug 11. doi: 10.1038/jid.2011.236 Source 1] Department of Basic Medical Sciences, College of Medicine Phoenix, University of Arizona, Phoenix, Arizona,...
Journal of the European Academy of Dermatology and Venereology Volume 25, Issue 7, pages 749–757, July 2011 Author Information 1. 1 Dermatology Department 2. 2 Vitiligo...
Br J Dermatol. 2011 Apr 1. doi: 10.1111/j.1365-2133.2011. Ho N, Pope E, Weinstein M, Greenberg S, Webster C, Krafchik BR. Source Section of Dermatology, Department of Paediatric...
We have opened a section with articles. You are welcome!
Articles LibraryVitiligo - a disease caused by a variety of reasons, beginning with formation of neoantigen, which starts the immune cellular response, leading to the destruction of...
Often, treatment options of vitiligo are limited with phototherapy, except for a small number of patients with resistant form of the disease, which can be treated with...
Over the years, the role of biochemical, immunological, genetic, and other biological aspects in the pathogenesis of vitiligo has been studied. So far, no convincing model...
Vitiligo is an ‘idiopathic’, acquired depigmenting disorder characterized by the loss of functional melanocytes from the epidermis. Several types of vitiligo...
1. Torello Lotti, 2. Alessia Gori, 3. Fabio Zanieri, 4. Roberta Colucci, 5. Silvia Moretti Article first published online: 3 APR 2008 DOI:...
Maxine E Whitton1, Mariona Pinart2, Jonathan Batchelor3, Clare Lushey4, Jo Leonardi-Bee5, Urbà González Treatments for vitiligo (a disease causing loss of skin...
1. N van Geel1, 2. S De Lille1, 3. S Vandenhaute1, 4. Y Gauthier2, 5. I Mollet1, 6. L Brochez1, 7. J Lambert1 Article first published online: 14 SEP 2010 DOI:...
The association with autoimmune disorders and organ specific antibodies as well as the fact that non-surgical repigmenting therapies have immune-modulating effects...
Vitiligo is an acquired depigmenting disorder characterized by the loss of melanocytes from the epidermis. Several types of vitiligo re distinguished according to the...
Article first published online: 28 APR 2010 DOI: 10.1111/j.1468-3083.2010.03694.x © 2010 The Authors. Journal of the European Academy of Dermatology and Venereology...
The non-profit VR Foundation accepts a variety of contributed material on vitiligo, melanoma and pigmentary disorders for possible inclusion on the website www.Vitinomics.net.
More...The 25June Initiative aims to increase awareness of vitiligo and raise funds for research, national vitiligo associations and support groups. Led by the VR Foundation, this year’s goal is to mark World Vitiligo Day on June 25 a date to be observed annually by the United Nations.
More...